A reappraisal of generic bisphosphonates in osteoporosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A reappraisal of generic bisphosphonates in osteoporosis

Published:2011-09-28 Issue:1 Volume:23 Page:213-221
ISSN:0937-941X
Container-title:Osteoporosis International
language:en
Short-container-title:Osteoporos Int

Author:

Kanis J. A.,Reginster J.-Y.,Kaufman J.-M.,Ringe J.-D.,Adachi J. D.,Hiligsmann M.,Rizzoli R.,Cooper C.

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism

Link

https://link.springer.com/content/pdf/10.1007/s00198-011-1796-6.pdf

Reference69 articles.

1. Kanis JA, Johnell O (2005) Requirements for DXA for the management of osteoporosis in Europe. Osteoporos Int 16:229–238

2. Delmas PD (2002) Treatment of postmenopausal osteoporosis. Lancet 359:2018–2026

3. Compston J, Cooper A, Cooper C et al (2009) Guidelines for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK. Maturitas 62:105–108

4. Van Staa TP (2006) The pathogenesis, epidemiology and management of glucocorticoid-induced osteoporosis. Calcif Tissue Int 79:129–137

5. Compston JE (2007) Emerging consensus on prevention and treatment of glucocorticoid-induced osteoporosis. Curr Rheumatol Rep 9:78–84

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antiresorptive Drugs’ Role in Management of Postmenopausal Osteoporosis;Endocrinology;2023-12-09

2. Meta-analysis of placebo-arm dropouts in osteoporosis randomized-controlled trials and implications for nocebo-associated discontinuation of anti-osteoporotic drugs in clinical practice;Osteoporosis International;2023-01-04

3. Pharmacological Treatment of Patients with Osteoporosis;Senior Trauma Patients;2022

4. Geroscience and Management of Osteoporosis in Older Adults;New Horizons in Osteoporosis Management;2022

5. Cost-effectiveness of buffered soluble alendronate 70 mg effervescent tablet for the treatment of postmenopausal women with osteoporosis in Italy;Osteoporosis International;2021-01-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3